Condition: Complicated Intra-abdominal Infections (cIAI) · Sponsor: Tetraphase Pharmaceuticals, Inc
A Phase 2 trial to assess safety, tolerability, and pharmacokinetics of eravacycline in pediatric patients aged 8 to \<18 years with cIAI.
This description comes directly from the study's public registry record.
ISTX Clinical Trials · 617-715-3600 · clinicaltrials@istx.com
Always discuss trial participation with your own doctor first.
| UCLA Ronald Reagan University of California Los Angeles Medical Center | Los Angeles, California, United States | Recruiting |
| Children's Hospital of Orange County | Orange, California, United States | Recruiting |
| Ann and Robert H Lurie Children's Hospital of Chicago | Chicago, Illinois, United States | Recruiting |
| Children's Hospital of LSU Health Sciences Center Shreveport | Shreveport, Louisiana, United States | Recruiting |
| West Virginia University Medicine Children's Hospital | Morgantown, West Virginia, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06794541